Radnet Inc (OQ:RDNT)
Business Focus: Medical & Diagnostic Laboratories
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 1510 Cotner Ave LOS ANGELES CA 90025 |
| Tel: | N/A |
| Website: | https://www.radnet.com |
| IR: | See website |
| Key People | ||
| Howard G. Berger Chairman of the Board, President, Chief Executive Officer | Mark D. Stolper Chief Financial Officer, Executive Vice President | Stephen M. Forthuber President, Chief Operating Officer- Eastern Operations |
| Norman R. Hames President, Chief Operating Officer - Western Operations | Mital Patel Executive Vice President - Financial Planning and Analysis, Chief Administrative Officer | Ranjan Jayanathan Executive Vice President, Chief Information Officer |
| David Jeffrey Katz Executive Vice President, General Counsel, Corporate Secretary | Michael M. Murdock Executive Vice President - Mergers and Acquisitions | Christine N. Gordon Senior Vice President of Operations, Northern California, Director |
| Business Overview |
| RadNet, Inc. is a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Company operates directly or indirectly through joint ventures with hospitals, approximately 351 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey and New York. The centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. The Company's services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company's Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. The Company's Artificial Intelligence segment develops and deploys clinical applications to enhance the interpretation of medical images. |
| Financial Overview |
| For the nine months ended 30 September 2022, Radnet Inc revenues increased 7% to $1.05B. Net income decreased 59% to $11.6M. Revenues reflect Service fee revenue increase of 6% to $667M, Revenue under capitation arrangements increase of 7% to $379.2M. Net income was offset by Depreciation and amortization increase of 20% to $85.2M (expense), Provider relief funding decrease from $6.3M (income) to $0K. |
| Employees: | 6,756 as of Dec 31, 2021 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $1,858M as of Sep 30, 2022 |
| Annual revenue (TTM): | $1,379M as of Sep 30, 2022 |
| EBITDA (TTM): | $164.11M as of Sep 30, 2022 |
| Net annual income (TTM): | $0.06M as of Sep 30, 2022 |
| Free cash flow (TTM): | -$11.17M as of Sep 30, 2022 |
| Net Debt Last Fiscal Year: | $651.28M as of Sep 30, 2022 |
| Shares outstanding: | 57,360,850 as of Nov 4, 2022 |
| Index Membership: | S&P 600 Small Cap |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2023 INK Research Corp. All rights reserved.
US Quotes Data provided by IEX. US Quotes Data provided by IEX. Company fundamental sourced from © Refinitiv. Click for restrictions. © Refinitiv. All rights reserved. Republication or redistribution of Refinitiv, including by framing or similar means, is prohibited without the prior written consent of Refinitiv. Refinitiv is not liable for any errors or delays in Refinitiv content, or for any actions taken in reliance on such content.
US Quotes Data provided by IEX. US Quotes Data provided by IEX. Company fundamental sourced from © Refinitiv. Click for restrictions. © Refinitiv. All rights reserved. Republication or redistribution of Refinitiv, including by framing or similar means, is prohibited without the prior written consent of Refinitiv. Refinitiv is not liable for any errors or delays in Refinitiv content, or for any actions taken in reliance on such content.